Genetic Technologies Ltd
NASDAQ:GENE

Watchlist Manager
Genetic Technologies Ltd Logo
Genetic Technologies Ltd
NASDAQ:GENE
Watchlist
Price: 0.765 USD
Market Cap: $2.5m

Operating Margin

-188.5%
Current
Declining
by 57.1%
vs 3-y average of -131.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-188.5%
=
Operating Income
AU$-7m
/
Revenue
AU$3.7m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-188.5%
=
Operating Income
$-7m
/
Revenue
AU$3.7m

Peer Comparison

Country Company Market Cap Operating
Margin
AU
Genetic Technologies Ltd
ASX:GTG
52.1m AUD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
241.5B USD
Loading...
US
Danaher Corp
NYSE:DHR
169.6B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
83.2T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.8B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.7B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
280.3B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
39.3B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.4B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.2B EUR
Loading...

Market Distribution

In line with most companies in Australia
Percentile
38th
Based on 3 951 companies
38th percentile
-188.5%
Low
-14 949 200% — -526.4%
Typical Range
-526.4% — 6.1%
High
6.1% — 145 596.9%
Distribution Statistics
Australia
Min -14 949 200%
30th Percentile -526.4%
Median -25.2%
70th Percentile 6.1%
Max 145 596.9%

Genetic Technologies Ltd
Glance View

Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company is headquartered in Melbourne, Victoria. The firm is focused on the development and commercialization of genetic risk assessment technology. The firm is engaged in providing genomics-based tests in health, wellness and serious disease through its GeneType and EasyDNA brands. GTG is focused on developing an integrated predictive genetic testing and assessment tools enabling medical practitioners and their patients to proactively manage health. The Company’s geneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type two diabetes in a single test. The GeneType offers integrated risk testing for a range of serious conditions. GTG offers cancer predictive testing and assessment tools for physicians. Its Polygenic Risk Scores (PRS) platform offers integrated clinical and genetic risk delivering actionable outcomes from physicians and individuals.

GENE Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-188.5%
=
Operating Income
AU$-7m
/
Revenue
AU$3.7m
What is Genetic Technologies Ltd's current Operating Margin?

The current Operating Margin for Genetic Technologies Ltd is -188.5%, which is below its 3-year median of -131.4%.

How has Operating Margin changed over time?

Over the last 3 years, Genetic Technologies Ltd’s Operating Margin has increased from -356.4% to -188.5%. During this period, it reached a low of -356.4% on Dec 31, 2021 and a high of -98% on Dec 31, 2022.

Back to Top